Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-14T08:07:51.486Z Has data issue: false hasContentIssue false
  • English
  • Français

Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours

Published online by Cambridge University Press:  16 April 2020

Mélanie M Ferrerri ,
Jean-Yves Loze ,
Frédéric Rouillon  and
Frédéric Limosin
Mélanie M Ferrerri
Affiliation:
Service de Psychiatrie, Hôpital Albert Chenevier, 40 rue de Mesly, 94010Créteil cedex, France
Jean-Yves Loze
Affiliation:
Service de Psychiatrie, Hôpital Albert Chenevier, 40 rue de Mesly, 94010Créteil cedex, France
Frédéric Rouillon
Affiliation:
Service de Psychiatrie, Hôpital Albert Chenevier, 40 rue de Mesly, 94010Créteil cedex, France
Frédéric Limosin*
Affiliation:
Service de Psychiatrie, Hôpital Albert Chenevier, 40 rue de Mesly, 94010Créteil cedex, France
*
*Corresponding author. E-mail address: frederic.limosin@wanadoo.fr (F. Limosin).
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

ClozapineBorderline Personality DisorderSelf-mutilation behavioursAnxiety
Type
Case report
Information
European Psychiatry , Volume 19 , Issue 3 , May 2004 , pp. 177 - 178
Copyright
Copyright © 2004 European Psychiatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alvir, JMJLieberman, JASafferman, AZSchwimmer, JLSchaaf, JA.Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 1993;329:162–7.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA; 1994.Google Scholar
Barnard, LYoung, AHPearson, JGeddes, JO’Brien, G.A systematic review of the use of atypical antipsychotics in autism. J Psychopharmacol 2002;16:93–101.CrossRefGoogle ScholarPubMed
Benedetti, FSforzini, LColombo, CMaffei, CSmeraldi, E.Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998;59:103–7.CrossRefGoogle ScholarPubMed
Chen, NCBedair, HSMcKay, BBowers, MB JrMazure, CClozapine in the treatment of aggression in an adolescent with autistic disorder. J Clin Psychiatry 2001;62:479–80.CrossRefGoogle Scholar
Chengappa, KNEbeling, TKang, JSLevine, JParepally, H.Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60:477–84.CrossRefGoogle ScholarPubMed
Frankenburg, FRZanarini, MCClozapine treatment of borderline patients: a preliminary study. Comprehensive Psychiatry 1993;34:402–5.CrossRefGoogle ScholarPubMed
Sajatovic, MRamirez, LFKenny, JTMeltzer, HY.The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients. Comprehensive Psychiatry 1994;35:29–33.CrossRefGoogle ScholarPubMed
Schotte, AJanssen, PFMegens, AALeysen, JE.Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 1993;631:191–202.CrossRefGoogle ScholarPubMed
Steinert, TSchmidt-Michel, POKaschka, WP.Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine. Pharmacopsychiat 1996;29:111–4.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.